Neuromed licenses the AurSCOPE Ion Channel database

Paris, France-based Aureus Pharma, a provider of knowledge management solutions to the life sciences industry, says that Canada's Neuromed Pharmaceuticals has licensed its AurSCOPE Ion Channel Knowledge database. Ion channels are a important therapeutic target for a number of diseases including cardiac arrthymias, auto-immune disorders and pain which is the major focus of Neuromed.

According to Aureus, its AurSCOPE Ion Channel database contains biological activity mined from the scientific literature for all known ion channels. This knowledge database can be used by pharmaceutical researchers to rapidly access prior knowledge related to ion channels for all stages of the drug discovery process. "We will leverage the data contained in the AurSCOPE Ion Channel knowledgebase to build upon Neuromed's existing expertise in ion channel biology and chemistry as we look to develop potentially new classes of medicines to treat pain," said Stephen Arneric, Neuromed's vice president, research and preclinical development.